Back to results
US 2019/0169192 A1Published application
Purinone derivative
AssigneeOno Pharmaceutical Co., Ltd.
InventorsShingo YAMAMOTO, Toshio YOSHIZAWA
Life of this patent
Estimating the term…
Abstract
Compounds represented by general formula (I) (all of the symbols in the formula conform to the definitions in the Description) are compounds that, in addition to having a Btk-selective inhibitory activity, exhibit an excellent metabolic stability and can avoid hepatotoxicity or the like, and as a consequence can provide safe therapeutic agents for diseases in which B cells or mast cells participate.
Claims11
1-17. (canceled)
A pharmaceutical composition comprising a compound of the following formula:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound of the following formula:
- or a pharmaceutically salt thereof, and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.